Physician profile
Gerald Mastaw
NPI 1316993454
$1,045.22
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $62.21 · 2022: $49.68 · 2023: $82.04 · 2024: $245 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $417.04 | 2019-2025 | Proclaim, Octrode, Eterna |
| Flowonix Medical Incorporated | $162.91 | 2019 | |
| Boston Scientific Corporation | $90.26 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Horizon Therapeutics Plc | $62.21 | 2020 | |
| Medtronic USA, INC. | $54.73 | 2019 | |
| Valinor Pharma, LLC | $52.13 | 2024-2025 | Movantik |
| Ibsa Pharma INC. | $45.83 | 2024 | Licart, Tirosint, Flector |
| Biodelivery Sciences International, INC. | $36.35 | 2019 | |
| Nevro Corp. | $32.39 | 2019 | |
| Stryker Corporation | $31.98 | 2019 | |
| Medtronic, INC. | $16.44 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.67 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.57 | 2019 | |
| Zyla Life Sciences, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Mastaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.